Dr. Kevin Duffy did not come to NWBO of his own accord as he returned to Merck. Merck has never put their name directly behind NWBO. The consultant that guided CRL to purchase Cognate was a former NWBO employee. There is a reason why the big names are quiet and it has to do with strategy. There will be big names attached/linked soon enough but because NWBO is carrying all the preparation load right now, shareholders will be very richly rewarded in the not too distant future. Let’s say a good start will be a 10X plus between now and end of 2024. How many folks/shares (non recycled) do you really think you are going to get convinced otherwise?; ). Best wishes.
News 
Market Data 
Discover 
